Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed Conditions
Clinical trial NCT04318535 · COMPLETED
Trial details
- NCT number
- NCT04318535
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-13
- Primary completion
- 2020-01-13
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.